Hikma’s Darwazah Advocates for Production Partnerships at Jordan-EU Investment Conference

Dead Sea:Hikma Pharmaceuticals' Executive Vice Chairman and Deputy CEO for MENA, Mazen Darwazah, highlighted the strategic position of Jordan as a gateway for European companies aiming to expand into regional markets. Speaking at the Jordan-EU Investment Conference, Darwazah emphasized the need for long-term production partnerships involving joint investment, technology transfer, and manufacturing, moving beyond traditional trade.

According to Jordan News Agency, Darwazah stated that Jordanian companies have the competitive edge and expertise to serve as operational partners for Europe across the Middle East and North Africa (MENA) region. By handling manufacturing, registration, and marketing of European products, local firms can alleviate European investors from dealing with individual regional market requirements.

Darwazah also noted Jordan's competitive advantages, including stability, developed infrastructure, a network of trade agreements, and a strategic geographic location. The country boasts a young, educated, multilingual workforce, producing approximately 90,000 graduates annually at competitive operating costs suitable for regional hubs and shared services.

He further highlighted the resilience of Jordanian industrial sectors in maintaining supply chain sustainability since the late 1970s, particularly noting their performance through the COVID-19 pandemic. Darwazah pointed out opportunities for integration with European partners in high-value-added manufacturing, energy, infrastructure, ICT, and apparel.

To advance up the value chain, Darwazah stressed the importance of localizing research and development and advanced pharmaceutical manufacturing in Jordan. This includes focusing on specialty drugs, biosimilars, and active pharmaceutical ingredients, in alignment with the Economic Modernization Vision targets.

He described the Jordan-EU partnership as mutually beneficial, with Europe providing technology and scale and Jordan offering market access, regulatory expertise, and human talent to foster sustainable job creation and shared growth. Hikma, founded in Jordan in 1978, now operates globally, offering a wide range of branded and non-branded generics while working to integrate innovative healthcare technologies worldwide.